[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [PBNCategory](https://github.com/mm80843/T3.5/tree/main/docs/PBNCategory/index.md) >> Individual ID:PBN__PBNCategory_131 

# __The challenges include inadequate testing capacity, slow identification of cases, limited evidence, and variability in PCR methods.__

## Items covered in this category

* [Identification of effective drug compounds](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3045.md)
* [Limited sample size in observational studies](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_814.md)
* [Need for alternative detection methods](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1152.md)
* [Concealment of mobility](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3209.md)
* [Mass testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_335.md)
* [Insufficient mass testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1030.md)
* [Invasive individual testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2367.md)
* [Low testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3166.md)
* [Testing strategy limitations](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1507.md)
* [Limited testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2721.md)
* [Limited diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2604.md)
* [Slow testing process](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_925.md)
* [Limited evidence available](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_402.md)
* [Barrier to accessing evidence in crisis](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_399.md)
* [Slow identification of cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_460.md)
* [Early Detection of Cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3283.md)
* [High number of undetected cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2977.md)
* [Detection of asymptomatic cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_636.md)
* [Insufficient surveillance of asymptomatic and unreported cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2167.md)
* [Underreporting of cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2180.md)
* [Under-reporting of cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_544.md)
* [Under-notification of cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1368.md)
* [Importation of cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1594.md)
* [High false positive rate](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3414.md)
* [Introduction of new cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2621.md)
* [Incomplete coverage of mild or asymptomatic cases](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1952.md)
* [Monitoring compliance of self-isolation](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3298.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2826.md)
* [Lack of standardization in PCR methods](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_635.md)
* [Limited sensitivity and accuracy of PCR methods](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1149.md)
* [Discrepancies in PCR results among laboratories](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1148.md)
* [Variability and specificity of PCR assays](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2339.md)
* [Long turnaround time for RT-PCR testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_673.md)
* [Diagnostic Accuracy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3291.md)
* [Need for improved detection methods](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_637.md)
* [Early detection](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3327.md)
* [Incomplete Detection](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2470.md)
* [Limited diagnostic and screening tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2185.md)
* [Insufficient testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_740.md)
* [Lack of quantitative evidence for UBPI](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_899.md)
* [Lack of quantitative evidence for the effectiveness of UBPI](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2242.md)
* [Monitoring of confirmed cases and close contacts](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2141.md)
* [Limited accuracy and specificity of biomarker measurements](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1156.md)
* [Imaging Limitation](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1267.md)
* [Cost and practicability of clinical testing and WBE](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1449.md)
* [Testing disparities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1936.md)
* [Swabbing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3452.md)

